March 8 (Reuters) - Exopharm :
* SIGNS BINDING AGREEMENT TO ACQUIRE TRYP THERAPEUTICS
* EXOPHARM INTENDS TO RAISE UP TO A$6.5 MILLION VIA A PUBLIC OFFER
* UNDERTAKEN INTERIM CAPITAL RAISE BY WAY OF CONVERTIBLE NOTE OF A$3.39 MILLION
* ACQUISITION WILL AMOUNT TO SIGNIFICANT CHANGE TO NATURE AND SCALE OF CO'S ACTIVITIES
* ISSUE PRICE OF A$0.02 PER SHARE FOR PUBLIC OFFER
* TO RAISE UP TO A$6.5 MILLION TO SUPPORT RESEARCH AND DEVELOPMENT OF TRYP'S LEAD PROGRAMS
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments